{"transactions":[{"id":807338,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-16T20:15:02.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":271600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following April 15, 2026, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":271600,"derivative":{"exercise_price":67.68,"expiration_date":"2036-04-14","underlying":"Common Stock","underlying_shares":271600},"source":{"system":"sec-edgar","filing":"0001193125-26-159024","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000119312526159024/ownership.xml","form_type":"4"}},{"id":844185,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-13T20:09:24.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":false,"shares":64612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is currently vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.72,"expiration_date":"2031-04-18","underlying":"Common Stock","underlying_shares":64612},"source":{"system":"sec-edgar","filing":"0002007101-26-000004","document":"form4-03132026_080321.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000200710126000004/form4-03132026_080321.xml","form_type":"4"}},{"id":844184,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-13T20:09:24.000Z","date":"2026-03-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1847,"price":60.15,"value":111097.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. The reporting person received 62,765 shares of common stock on net exercise of an option to purchase 64,612 shares of common stock. The Company withheld 1,847 shares of common stock underlying the option and the reporting person paid in cash the delta for payment in full of the aggregate exercise price. This transaction does not represent a sale by the reporting person."}],"balance_after":198916,"source":{"system":"sec-edgar","filing":"0002007101-26-000004","document":"form4-03132026_080321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000200710126000004/form4-03132026_080321.xml","form_type":"4"}},{"id":844183,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-13T20:09:24.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":true,"shares":64612,"price":1.72,"value":111132.64,"ownership":{"direct":true},"balance_after":200763,"source":{"system":"sec-edgar","filing":"0002007101-26-000004","document":"form4-03132026_080321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000200710126000004/form4-03132026_080321.xml","form_type":"4"}},{"id":856199,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-06T22:52:13.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":false,"shares":102871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is currently vested and exercisable."}],"balance_after":64612,"derivative":{"exercise_price":1.72,"expiration_date":"2031-04-18","underlying":"Common Stock","underlying_shares":102871},"source":{"system":"sec-edgar","filing":"0002007101-26-000002","document":"form4-03062026_100310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000200710126000002/form4-03062026_100310.xml","form_type":"4"}},{"id":856198,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-06T22:52:13.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2871,"price":61.61,"value":176882.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. The reporting person received 100,000 shares of common stock on net exercise of an option to purchase 102,871 shares of common stock. The Company withheld 2,871 shares of common stock underlying the option and the reporting person paid in cash the delta for payment in full of the aggregate exercise price. This transaction does not represent a sale by the reporting person."}],"balance_after":136151,"source":{"system":"sec-edgar","filing":"0002007101-26-000002","document":"form4-03062026_100310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000200710126000002/form4-03062026_100310.xml","form_type":"4"}},{"id":856197,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-06T22:52:13.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":true,"shares":102871,"price":1.72,"value":176938.12,"ownership":{"direct":true},"balance_after":139022,"source":{"system":"sec-edgar","filing":"0002007101-26-000002","document":"form4-03062026_100310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000200710126000002/form4-03062026_100310.xml","form_type":"4"}},{"id":1171114,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-16T20:15:18.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":527660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following April 15, 2025, the vesting commencement date, subject to the Report Person's continuous service to the Issuer through each vesting date."}],"balance_after":527660,"derivative":{"exercise_price":20.11,"expiration_date":"2035-04-14","underlying":"Common Stock","underlying_shares":527660},"source":{"system":"sec-edgar","filing":"0000950170-25-054742","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000095017025054742/ownership.xml","form_type":"4"}},{"id":1390283,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-07T20:51:28.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":397800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following October 4, 2024, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":397800,"derivative":{"exercise_price":36.63,"expiration_date":"2034-10-03","underlying":"Common Stock","underlying_shares":397800},"source":{"system":"sec-edgar","filing":"0000950170-24-113282","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000095017024113282/ownership.xml","form_type":"4"}}]}